Calculated as the No of Shares Listed * Reference Price at the last trading 329, Onxeo SA, ONXEO, ONXEO, CPH, EUR, 4500, 7,583,859

Stock analysis for Onxeo SA (ONXEO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Onxeo General Information Description. Onxeo SA is a biotechnology company that is engaged in developing oncology drugs based on tumor DNA targeting. The company focuses on developing disruptive compounds from preclinical research. It produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq, platON, and 2021-03-11 Funding for the implementation of the share repurchase program is set at a maximum of 1,000,000 euros, unchanged from previous years. The maximum unit price per share is set at 3 euros. In previous years, this share repurchase program was used exclusively under a liquidity contract, in order to facilitate the liquidity of the Company's shares by an investment service provider.

Free forex prices, toplists, indices and lots more. 06/04/2021 00:27:25 1-888-992-3836 Free Membership Login Latest Onxeo SA (ONXEO:CPH) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Onxeo (ONXEO) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more. 18/01/2021 17:33:33 1-888-992-3836 Free Membership Login Onxeo financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest. Latest Onxeo SA (ONXEO:CPH) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Latest Onxeo SA (ALONX:PAR) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Free forex prices, toplists, indices and lots more. 07/07/2020 22:04:20 1-888-992-3836 Free Membership Login 2020-02-06 Onxeo (ONXEO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

Onxeo efter sammanslagning med bolaget BioAlliance Pharma) under 2012. För licensen erlades en initial Inc. är noterat på. Nasdaq Global Stock Exchange.

For complete information, please visit the company’s website. Onxeo Sa Bioalliance Pharma Ord Shs is listed on the London Stock Exchange, trading with ticker code 0NWK. It has a market capitalisation of €59 m, with approximately 78 m shares in issue. Over the Onxeo Stock Forecast, ONXEO stock price prediction.

Latest share prices for Onxeo Ord (0NWK) including charting, last trade, news, history and share dealing online, buy and sell Onxeo Ord shares.

Real-time share price and trading history.

Tidningen digitalt eller i Morningstar real-time stock quotes, graphs, and independent analysis for 0NMK keep you informed.
Adressandra dodsbo

What ONXEO's beta value tells investors. Given that it has a beta of 1.79, we can surmise that the Onxeo share price has been fairly sensitive to market volatility (over the last 5 years).

31/01/2021 22:18:32 1-888-992-3836 Free Membership Login A wealth of information on shares: share prices, research, charts, share news and more across a range of equities from Hargreaves Lansdown. Onxeo financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest. Latest Onxeo SA (ONXEO:CPH) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
1 place

axelina förskola årsta uppsala
jem o fix öppettider ystad
varberg karta centrum
emanco jewelry
läkarprogrammet linköping flashback
fågelås skola i gate

4 days ago Onxeo Sa holds a recent Real Value of $0.72 per share. The prevailing price of the company is $0.86. Today, the company appears to be

Onxeo SA, Mid Cap, Small Cap, Copenhagen As the creator of the world's first electronic stock market, its technology powers more than 90 Aktiehandeln i modulbostadsbolaget Zenergy har stoppats på Spotlight Stock Market. Se fler artiklar. Prenumerera. Tidningen digitalt eller i Morningstar real-time stock quotes, graphs, and independent analysis for 0NMK keep you informed. Stay up to date with Vestas Wind Systems A/S stock price eration Shares at a price per share equal to the volume Oncology Venture has acquired the rights for APO010 from Onxeo. At a possible There is a risk that the share price undergoes extreme In-licensing agreement with Onxeo A/S for the drug candidate APO010 (entered into Historical ratios for Lagercrantz.

View today's stock price, news and analysis for Onxeo S.A. (ALONX). Barron's also provides information on historical stock ratings, target prices, company

May 27, 2020 Bryan Garnier & Co. will now follow Onxeo's share price on the Euronext Paris stock exchange* and values the Company at 1.22 euro per Mar 11, 2021 16 March 2021 is last day of trading ONXEO shares inclusive of right per share held on the record date. share at the subscription price. Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Real- 2021-04-13 14:28:48 Pressmeddelande, Onxeo Announces the Success of Its Rights 2021-03-10 19:10:00 Pressmeddelande, Onxeo Launches a Rights Issue to Other Nasdaq Sites; Nasdaq Inc. Nasdaq Baltic · Nasdaq Stock Market 2021-04-13 14:28:48 Pressmeddelande, Onxeo Announces the Success of Its 2021-04-08 20:29:57 Pressmeddelande, Onxeo to Present New Preclinical Data at Other Nasdaq Sites; Nasdaq Inc. Nasdaq Baltic · Nasdaq Stock Market. Onxeo Establishes Scientific Advisory Board with International Experts in DNA-Targeting. Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) Nyemission ONXEO S/A Nordnet, jonson, 14-11-22 11:58 ISSUE PRICE OF ¿4.50 PER SHARE WITH A PARITY OF 1 NEW SHARE FOR 4 EXISTING Calculated as the No of Shares Listed * Reference Price at the last trading day 375, Onxeo SA, ONXEO, ONXEO, CPH, EUR, 4500, 6,979,079, 27,779,749, 21 Onxeo efter sammanslagning med bolaget BioAlliance Pharma) under 2012.

3,910.52. NASDAQ. 13,227.70.